Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 1, 2000, Pages 73-77

  Moretti, Maria Vittoria ^a   Pauluzzi, Sergio ^a   Cesana, Marina ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Mediolanum Farmaceutici   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RUFLOXACIN;

ADULT; AGED; ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG PENETRATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0033988227     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.1.73-77.2000     Document Type: Article

References (29)

1. Asuquo, A. E., and L. J. V. Piddock. 1993. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 31:865-880.
2. Barling, R. W. A., and J. B. Selkon. 1978. The penetration of antibiotics into cerebrospinal fluid and brain tissue. J. Antimicrob. Chemother. 4:203-227.
3. Cogo, R., R. Rimoldi, R. Mattina, and B. P. Imbimbo. 1992. Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infections. Ther. Drug Monit. 14:36-41.
4. Davey, P. G., T. McDonald, and G. Lindsay. 1991. Post-marketing surveillance of quinolones 1988-1990. Eur. J. Clin. Microbiol. Infect Dis. 10: 384-389.
5. A receptor of rat vagus nerve. Antimicrob. Agents Chemother. 38:1356-1362.
6. Durand, M. L., S. B. Calderwood, D. J. Weber, S. I. Miller, F. S. Southwick, V. S. Caviness, Jr., and M. N. Swartz. 1993. Acute bacterial meningitis in adults. A review of 493 episodes. N. Engl. J. Med. 328:21-28.
7. Festa, M. R. 1989. An analytical investigation on rufloxacin hydrochloride Exedra 3:15-20.
8. Furneri, P. M., M. Bazzano, L. Campo, M. Cesana, and G. Tempera. 1994. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis. Chemotherapy 40:104-108.
9. A receptors by 4-quinolones. J. Antimicrob. Chemother. 31:457-462.
10. Hooper, D. C., and J. S. Wolfson. 1991. Fluoroquinolone antimicrobial agents. N. Engl. J. Med. 324:384-393.
11. Ichikawa, N., K. Noara, and K. Iwamoto. 1994. Comparative study of permeability into rat cerebrospinal fluid of the quinolones: dependency on their lipophilicities. Biol. Pharm. Bull. 17:152-155.
12. Imbimbo, B. P., G. Broccali, M. Cesana, F. Crema, and G. Attardo-Parrinello. 1991. Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers. Antimicrob. Agents Chemother. 35:390-393.
13. Jaehde, U., T. Goto, A. G. de Boer, and D. D. Breimer. 1993. Blood-brain barrier transport rate of quinolone antibacterials evaluated in cerebrovascular endothelial cell cultures. Eur. J. Pharm. Sci. 1:49-55.
14. Karabalut, N., and G. L. Drusano. 1993. Pharmacokinetics of the quinolone antimicrobial agents, p. 195-223. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents, 2nd ed. American Society for Microbiology, Washington, D.C.
15. Kisicki, J. C., R. S. Griess, C. L. Ott, G. M. Cohen, R. J. McCormack, W. M. Troetel, and B. P. Imbimbo. 1992. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers. Antimicrob. Agents Chemother. 36:1296-1301.
16. Mattina, R., C. E. Cocuzza, M. Cesana, and G. Bonfiglio. 1991. In vitro activity of a new quinolone, rufloxacin, against nosocomial isolates. Chemotherapy 37:260-269.
17. Nau, R., H. W. Prange, S. Menck, H. Kolenda, K. Visser, and K. Seydel. 1992. Passage of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges. J. Antimicrob. Chemother. 29:719-724.
18. Nau, R., G. Zysk, A. Thiel, and H. W. Prange. 1993. Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man. Eur. J. Pharmacol. 45:469-475.
19. Nau, R., M. Kinzig, T. Dreyhaupt, H. Kolenda, F. Sörgel, and H. W. Prange. 1994. Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin. Antimicrob. Agents Chemother. 38:1849-1853.
20. Nix, D. E. 1993. Drug-drug interactions with fluoroquinolone antimicrobial agents, p. 245-258. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents, 2nd ed. American Society for Microbiology, Washington, D.C.
21. Ooie, T., H. Suzuki, T. Terasaki, and Y. Sugiyama. 1996. Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. J. Pharmacol. Exp. Ther. 278:590-596.
22. Price, R. W. 1996. Acute viral meningitis and encephalitis, p. 2088. In J. C. Bennett and F. Plum (ed.), Cecil textbook of medicine. The W. B. Saunders Company, Philadelphia, Pa.
23. Quagliarello, V. J., and W. M. Scheld. 1997. Treatment of bacterial meningitis. N. Engl. J. Med. 336:708-716.
24. Schito, G. C., J. F. Acar, A. Bauernfeind, J. Duval, R. G. Finch, J. Focht, G. Nicoletti, I. Phillips, G. Pratts, F. Soriano, B. Wiedemann, and R. Wise. 1996. A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens. J. Antimicrob. Chemother. 38:627-639.
25. Täuber, M. G., and M. A. Sande. 1990. General principles of therapy of pyogenic meningitis. Infect. Dis. Clin. N. Am. 4:661-676.
26. Wise, R., J. Johnson, N. O'Sullivan, J. M. Andrews, and B. P. Imbimbo. 1991. Pharmacokinetics and tissues penetration of rufloxacin, a long acting quinolone antimicrobial agent. J. Antimicrob. Chemother. 28:905-909.
27. Wise, R., J. M. Andrews, R. Matthews, and M. Wolstenholme. 1992. The in-vitro activity of two new quinolones: rufloxacin and MF 961. J. Antimicrob. Chemother. 29:649-660.
28. Wise, R., J. Andrews, B. P. Imbimbo, and D. Honeybourne. 1993. The penetration of rufloxacin into sites of potential infection in the respiratory tract. J. Antimicrob. Chemother. 32:861-866.
29. Wolff, M., L. Boutron, E. Singlas, B. Clair, J. M. Decazes, and B. Regnier. 1987. Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. Antimicrob. Agents Chemother. 31:899-902.